Assay conditions for estimating differences in base excision repair activity with Fpg-modified comet assay

Cell Biol Toxicol. 2023 Dec;39(6):2775-2786. doi: 10.1007/s10565-023-09801-0. Epub 2023 Mar 17.

Abstract

DNA repair is an essential agent in cancer development, progression, prognosis, and response to therapy. We have adapted a cellular repair assay based on the formamidopyrimidine DNA glycosylase (Fpg)-modified comet assay to assess DNA repair kinetics. The removal of oxidized nucleobases over time (0-480 min) was analyzed in peripheral blood mononuclear cells (PBMCs) and 8 cell lines. DNA damage was induced by exposure to either Ro19-8022 plus visible light or potassium bromate (KBrO3). The initial amount of damage induced by Ro 19-8022 plus light varied between cell lines, and this was apparently associated with the rate of repair. However, the amount of DNA damage induced by KBrO3 varied less between cell types, so we used this agent to study the kinetics of DNA repair. We found an early phase of ca. 60 min with fast removal of Fpg-sensitive sites, followed by slower removal over the following 7 h. In conclusion, adjusting the initial damage at T0 to an equal level can be achieved by the use of KBrO3, which allows for accurate analysis of subsequent cellular DNA repair kinetics in the first hour after exposure.

Keywords: Antioxidant status; Cellular repair; Comet assay; DNA repair capacity; Fpg.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Comet Assay
  • DNA Damage
  • DNA Repair*
  • DNA-Formamidopyrimidine Glycosylase / metabolism
  • Leukocytes, Mononuclear*

Substances

  • DNA-Formamidopyrimidine Glycosylase